| Cherie Renee Hart-spicer, MD | |
|
155 5th St Ne, Barberton, OH 44203-3332 | |
| (330) 615-3966 | |
| (330) 615-3985 |
| Full Name | Cherie Renee Hart-spicer |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 19 Years |
| Location | 155 5th St Ne, Barberton, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366636912 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 35.092892 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Summa Health System | Akron, OH | Hospital |
| Crystal Clinic Orthopaedic Center | Akron, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Summit Pathology Associates, Inc | 2769442193 | 9 |
News Archive
LSU has received a $15 million grant from the National Institutes of Health, or NIH, IDeA Networks of Biomedical Research Excellence, or INBRE, program. The grant is centered in the School of Veterinary Medicine, or SVM, and the Department of Biological Science in the LSU College of Science. The purpose of this five-year grant is to strengthen the biomedical research infrastructure and work force within Louisiana.
National Institutes of Health scientists studying the progression of inherited and infectious eye diseases that can cause blindness have found that microglia, a type of nervous system cell suspected to cause retinal damage, surprisingly had no damaging role during prion disease in mice.
IBM and Cellomics have announced they have launched a customized information technology (IT) solution that allows biopharmaceutical scientists and academic researchers to better understand how potential drug candidates or targets of interest affect cellular function.
UMass Medical School (UMMS) recognizes the launch today of Voyager Therapeutics, a gene therapy company founded by four world leaders in the fields of AAV gene therapy, RNA biology and neuroscience, to develop life-changing treatments for fatal and debilitating diseases of the central nervous system (CNS).
› Verified 9 days ago
| Entity Name | Summit Pathology Associates, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952362063 PECOS PAC ID: 2769442193 Enrollment ID: O20041012000193 |
News Archive
LSU has received a $15 million grant from the National Institutes of Health, or NIH, IDeA Networks of Biomedical Research Excellence, or INBRE, program. The grant is centered in the School of Veterinary Medicine, or SVM, and the Department of Biological Science in the LSU College of Science. The purpose of this five-year grant is to strengthen the biomedical research infrastructure and work force within Louisiana.
National Institutes of Health scientists studying the progression of inherited and infectious eye diseases that can cause blindness have found that microglia, a type of nervous system cell suspected to cause retinal damage, surprisingly had no damaging role during prion disease in mice.
IBM and Cellomics have announced they have launched a customized information technology (IT) solution that allows biopharmaceutical scientists and academic researchers to better understand how potential drug candidates or targets of interest affect cellular function.
UMass Medical School (UMMS) recognizes the launch today of Voyager Therapeutics, a gene therapy company founded by four world leaders in the fields of AAV gene therapy, RNA biology and neuroscience, to develop life-changing treatments for fatal and debilitating diseases of the central nervous system (CNS).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cherie Renee Hart-spicer, MD 525 E Market St, Akron, OH 44304-1619 Ph: () - | Cherie Renee Hart-spicer, MD 155 5th St Ne, Barberton, OH 44203-3332 Ph: (330) 615-3966 |
News Archive
LSU has received a $15 million grant from the National Institutes of Health, or NIH, IDeA Networks of Biomedical Research Excellence, or INBRE, program. The grant is centered in the School of Veterinary Medicine, or SVM, and the Department of Biological Science in the LSU College of Science. The purpose of this five-year grant is to strengthen the biomedical research infrastructure and work force within Louisiana.
National Institutes of Health scientists studying the progression of inherited and infectious eye diseases that can cause blindness have found that microglia, a type of nervous system cell suspected to cause retinal damage, surprisingly had no damaging role during prion disease in mice.
IBM and Cellomics have announced they have launched a customized information technology (IT) solution that allows biopharmaceutical scientists and academic researchers to better understand how potential drug candidates or targets of interest affect cellular function.
UMass Medical School (UMMS) recognizes the launch today of Voyager Therapeutics, a gene therapy company founded by four world leaders in the fields of AAV gene therapy, RNA biology and neuroscience, to develop life-changing treatments for fatal and debilitating diseases of the central nervous system (CNS).
› Verified 9 days ago
Mark Edgar Parker, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 155 5th Street Ne, Barberton, OH 44203 Phone: 303-861-2098 | |
Roger Vernon Donohoo, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 155 5th Street Ne, Barberton, OH 44203 Phone: 303-861-2098 | |
Joel Brian Miller, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 155 5th Street Ne, Barberton, OH 44203 Phone: 303-861-2098 |